- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
BMY
Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year
BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.
Best Stocks for 2022: Bristol-Myers Squibb Isn’t Done Growing
It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.